Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung canc
2017-12-08 07:18來源：原版作者：Hou JM
Circulating tumor cells (CTCs) may have utility as surrogate biomarkers and "virtual" biopsies. We report the clinical significance and molecular characteristics of CTCs and CTC clusters, termed circulating tumor microemboli (CTM), detected in patients with small-cell lung cancer (SCLC) undergoing standard treatment.
PATIENTS AND METHODS:
Serial blood samples from 97 patients receiving chemotherapy were analyzed using EpCam-based immunomagnetic detection and a filtration-based technique. Proliferation status (Ki67) and apoptotic morphology were examined. Associations of CTC and CTM number with clinical factors and prognosis were determined.
CTCs were present in 85% of patients (77 of 97 patients) and were abundant (mean ± standard deviation = 1,589 ± 5,565). CTM and apoptotic CTCs were correlated with total CTC number and were detected in 32% and 57% of patients, respectively. Pretreatment CTCs, change in CTC number after one cycle of chemotherapy, CTM, and apoptotic CTCs were independent prognostic factors. Overall survival was 5.4 months for patients with ≥ 50 CTCs/7.5 mL of blood and 11.5 months (P < .0001) for patients with less than 50 CTCs/7.5 mL of blood before chemotherapy (hazard ratio = 2.45; 95% CI, 1.39 to 4.30; P = .002). Subpopulations of apoptotic and of proliferating solitary CTCs were detected, whereas neither were observed within cell clusters (CTM), implicating both protection from anoikis and relative resistance to cytotoxic drugs for cells within CTM.
Both baseline CTC number and change in CTC number after one cycle of chemotherapy are independent prognostic factors for SCLC. Molecular comparison of CTCs to cells in CTM may provide novel insights into SCLC biology.
上一篇：Circulating tumor cells in peripheral and pulmonary venous blood predict poor long-term survival in resected non-small cell lung cancer patients.
下一篇：Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.返回首頁
- > 《醫學拾萃》2022年12月刊：血清分離技術及其對臨床生化檢驗結果的影響
- > 《醫學拾萃》2022年10月刊：標本處理對心肌肌鈣蛋白測定的影響
- > 《醫學拾萃》2022年8月刊：一種新型材料－水凝膠的合成及其應用
- > 《醫學拾萃》2022年6月刊：RFID 技術及其在醫療和標本管理中的應用與發展
- > 《醫學拾萃》2022年4月刊：血凝管臨床適用檢測項目與不適應癥
- > 《醫學拾萃》2022年2月刊：分離膠促凝管臨床適用檢測項目與不適應癥
- > 《醫學拾萃》2021年12月刊：醫護人員針刺傷害現狀及預防措施
- > 《醫學拾萃》2021年10月刊：末梢采血技術及其臨床應用
- > 《醫學拾萃》2021年8月刊：微生物拭子的應用及研究發展?
- > 《醫學拾萃》2021年6月刊：循環腫瘤細胞檢測中血液采集和樣本保存的研究進展